Moreover, a systematic review and meta-analysis by Akdeniz et al. [50] has recently shown a strong association with contralateral BC for carriers of CHEK2 c.1100delC mutation (relative risk, 2.7). The gene discussed is CHEK2; the disease is breast cancer.